San Diego Business Journal


Recent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...

La Jolla Pharmaceutical Stock Surges

La Jolla Pharmaceutical Co.’s stock surged by more than 17 percent last week, spurred by director Kevin Tang’s purchase of 53,836 shares last Tuesday.

Palomar Board Votes to Close Hospital

Palomar Health’s Board of Directors voted June 24 to close Palomar Health Downtown Hospital in Escondido.

Backers Put Big Money Behind Spinal Fusion Therapeutic

La Jolla-based Avalon Ventures led a $17 million Series A round for Ankasa Regenerative Therapeutics, handing over $8.5 million of the funding to the upstart biotech working on new tech for reactivating stem cells and tissue regeneration.

Tease photo

Portable PET Scanners to Deliver Diagnostics to Doctors’ Offices

BIOTECH: Current Scanners Cumbersome Costly and Overbooked

Local startup JAS Neuro Imaging has forged a partnership with Maryland-based Brain Biosciences to bring breakthrough brain technology directly to the doctor’s office.

Prebys Donates $100M to Sanford-Burnham

The Sanford-Burnham Medical Research Institute has received a gift of $100 million from prominent San Diego developer and philanthropist Conrad Prebys.

Tease photo

Celladon Suspending R&D Activities

Celladon Corp. announced that it will suspend all research and development activities.

Tease photo

There at the Start(up)

BIOTECH: Hybritech’s Story Is First Chapter of S.D.’s Biotech Biography

The name Hybritech is pinned to local resumes like a badge of honor, as if to say, “I was here in the beginning.”

Richard Slansky Appointed CFO at OncoSec Medical Inc.

OncoSec Medical Inc., a company developing cancer immunotherapies, announced Thursday the appointment of Richard B. Slansky as chief financial officer effective July 6.

Palomar Health to Close Downtown Escondido Hospital

Palomar Health's Board of Directors voted Wednesday night to close Palomar Health Downtown Hospital in Escondido.

Aethlon Medical Enters $6 Million Stock Purchase Agreement

San Diego-based Aethlon Medical Inc., a medical device company developing therapies for infectious diseases and cancer, announced Wednesday that it entered into a definitive $6 million stock purchase agreement.

FDA Grants ARK Animal Health MUMS Drug Designation

ARK Animal Health Inc., a wholly-owned subsidiary of San Diego-based Sorrento Therapeutics Inc., was granted a Minor Use/Minor Species (MUMS) Drug Designation for its pain drug, ARK-001, for dogs with bone cancer.

Conrad Prebys Donates $100 Million to Sanford-Burnham Institute

The Sanford-Burnham Medical Research Institute announced Wednesday that it has received a gift of $100 million from prominent San Diego developer and philanthropist Conrad Prebys.

Imprimis Acquires Rights to Sedation Formulations

Imprimis Pharmaceuticals Inc. has acquired the rights to novel sedation and analgesia/anesthesia formulations that can block pain and sedate patients undergoing ocular and other surgical procedures.

Premier Inc. Awards AMN Healthcare Sole Source Contract

San Diego’s AMN Healthcare Services, the country’s largest provider of health care staffing services, has won a sole source contract with Premier Inc. to offer staffing services and workforce solutions to its alliance of about 3,400 hospitals and 110,000 other health care facilities.

Ambrx Inc. Appoints CEO, Chief Science Officer

Ambrx Inc., a San-Diego based biotechnology company, has named Tiecheng (Alex) Qiao its CEO effective immediately.